Does casein phosphopeptid amorphous calcium phosphate provide remineralization on white spot lesions and inhibition of Streptococcus mutans?
dc.contributor.author | Aykut-Yetkiner A. | |
dc.contributor.author | Kara N. | |
dc.contributor.author | Ateş M. | |
dc.contributor.author | Ersin N. | |
dc.contributor.author | Ertuğrul F. | |
dc.date.accessioned | 2019-10-26T21:27:42Z | |
dc.date.available | 2019-10-26T21:27:42Z | |
dc.date.issued | 2014 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: The aim of this study was to evaluate the remineralization effect of Casein Phosphopeptid Amorphous Calcium Phosphate (CPP-ACP) on white spot lesions (WSL) and its inhibitory effect on Streptococcus mutans colonization.STUDY DESIGN: The study group consisted of 60 children exhibiting at least 1-WSL. Subjects were randomly divided into 2 groups: a test group of using CPP-ACP cream (Tooth Mousse, GC Europe N.V., Leuven, Belgium) and a control group using only fluoride containing toothpaste for a period of 3-months. Baseline WSLs were scored using DIAGNOdent device (KaVo Germany) and the saliva samples were collected to measure S. mutans counts. After the 3-month period the WSLs were again recorded and the saliva sample collection was repeated. Wilcoxon Signed Ranks Test was used for statistical analysis.RESULTS: DIAGNOdent measurements were increased by time (p = 0.002) in control group and no statistically significant diference (p = 0.217) was found in test group by the 3-month period. In both groups, the mutans counts were decreased in 3-month experimental period.CONCLUSIONS: These clinical and laboratory results suggested that CPP-ACP containing cream had a slight remineralization effect on the WSL in the 3-month evaluation period however longer observation is recommended to confirm whether the greater change in WSLs is maintained. | en_US |
dc.identifier.doi | 10.17796/jcpd.38.4.b4q401v6m4818215 | en_US |
dc.identifier.endpage | 306 | en_US |
dc.identifier.issn | 1053-4628 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 25571679 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 302 | en_US |
dc.identifier.uri | https://doi.org/10.17796/jcpd.38.4.b4q401v6m4818215 | |
dc.identifier.uri | https://hdl.handle.net/11454/17431 | |
dc.identifier.volume | 38 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | The Journal of clinical pediatric dentistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Does casein phosphopeptid amorphous calcium phosphate provide remineralization on white spot lesions and inhibition of Streptococcus mutans? | en_US |
dc.type | Article | en_US |